Current state and prospects of biotechnology in Central and Eastern European countries. Part I: Visegrad countries (CZ, H, PL, SK)

Markus Dettenhofer , Miroslav Ondrejovič , Viktoria Vasary , Paweł Kaszycki , Tomasz Twardowski , Stanislav Stuchlik , Jan Turna , Munis Dundar , Kevan M. A. Gartland , Stanislav Miertus

Abstract

Innovation is a key determinant of sustainable growth. Biotechnology (BT) is one such industry that has witnessed a revolution in innovative ideas leading to the founding of many new companies based on providing products, solutions and services, stretching from the food industry to environmental remediation, and new medicines. BT holds much promise for the development of national and local economies, however, this requires a strategic approach involving actors within government, industry, and academia working in concert to maximize this potential. This first article reviews the current “state of play” in the field of BT within the Central Eastern European (CEE) countries. For the purposes of this article, CEE refers to the countries of Czech Republic, Hungary, Poland, and Slovakia (the so-called Visegrad – V4 countries). We examine the components that support the creation and development of a BT sector in CEE and also highlight the barriers to these objectives. Clearly setting priorities for the countries’ policy agenda, as well as the alignment of Smart Specialization Strategy will help to focus efforts. Recent investments in R&D infrastructure within CEE have been substantial, but conditions will need to be optimized to harness these largely European investments for effective use towards SME high-tech development.
Author Markus Dettenhofer
Markus Dettenhofer,,
-
, Miroslav Ondrejovič
Miroslav Ondrejovič,,
-
, Viktoria Vasary
Viktoria Vasary,,
-
, Paweł Kaszycki (FoBaH / IoPBaB)
Paweł Kaszycki,,
- Institute of Plant Biology and Biotechnology
, Tomasz Twardowski
Tomasz Twardowski,,
-
, Stanislav Stuchlik
Stanislav Stuchlik,,
-
, Jan Turna
Jan Turna,,
-
, Munis Dundar
Munis Dundar,,
-
, Kevan M. A. Gartland
Kevan M. A. Gartland,,
-
, Stanislav Miertus
Stanislav Miertus,,
-
Journal seriesCritical Reviews in Biotechnology, ISSN 0738-8551, e-ISSN 1549-7801, (N/A 140 pkt)
Issue year2019
Vol39
No1
Pages114-136
Publication size in sheets1.1
Keywords in EnglishBiotechnology (BT), Central Eastern Europe (CEE), Visegrad countries (V4), Smart Specialization Strategy (RIS3), higher education, public financing science, venture capital
ASJC Classification2700 General Medicine; 1305 Biotechnology; 2402 Applied Microbiology and Biotechnology
DOIDOI:10.1080/07388551.2018.1523131
URL https://www.tandfonline.com/doi/abs/10.1080/07388551.2018.1523131?journalCode=ibty20
Internal identifierWBIO/2019/4
Languageen angielski
Score (nominal)140
Score sourcejournalList
Publication indicators WoS Citations = 2; Scopus SNIP (Source Normalised Impact per Paper): 2018 = 1.989; WoS Impact Factor: 2018 = 7.054 (2) - 2018=7.125 (5)
Citation count*
Additional fields
FinansowanieThis work was supported by Agentúra na Podporu Výskumu a Vývoja. This work was also supported by the Slovak Research and Development Agency grants APVV-14–0294, APVV-14-0393, APVV-15-0111, APVV-16-0088, and APVV-17-0239.
Cite
Share Share

Get link to the record


* presented citation count is obtained through Internet information analysis and it is close to the number calculated by the Publish or Perish system.
Back
Confirmation
Are you sure?